gavel-pills-istock-525883642-vnphotolab-
AVNphotolab / iStockphoto.com
11 June 2018Americas

Takeda v Zydus: FTC intervenes in sham lawsuit claims

The US Federal Trade Commission ( FTC) has filed an amicus brief urging a district court to reject Takeda’s claim that its patent infringement lawsuit brought under the Hatch-Waxman Act cannot be a sham.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
13 March 2017   Speciality pharmaceutical company Supernus has settled patent disputes over Trokendi XR, a treatment for partial seizures, with US-based Zydus Pharmaceuticals and Actavis Laboratories.

More on this story

Big Pharma
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
13 March 2017   Speciality pharmaceutical company Supernus has settled patent disputes over Trokendi XR, a treatment for partial seizures, with US-based Zydus Pharmaceuticals and Actavis Laboratories.

More on this story

Big Pharma
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
13 March 2017   Speciality pharmaceutical company Supernus has settled patent disputes over Trokendi XR, a treatment for partial seizures, with US-based Zydus Pharmaceuticals and Actavis Laboratories.